SCYNEXIS Stock

SCYNEXIS Tax Expense

The Income Tax Expense of SCYNEXIS (SCYX) as of Aug 19, 2026 is 151,000.00 USD. In the previous year, Income Tax Expense was 138,000.00 USD — a change of 9.42% (higher).

Tax Expense

151,000.00USD

YoY

9.42%

Last updated:

Income Tax Expense of SCYNEXIS is 2026 151,000.00 USD. Income Tax Expense of SCYNEXIS was 2025 138,000.00 USD. It decreases by 9.42% higher compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Income Tax Expense of SCYNEXIS is 151,000.00 USD in 2026.

Income Tax Expense of SCYNEXIS changed from 138,000.00 USD to 151,000.00 USD, representing a 9.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Income Tax Expense SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Tax expense represents the total income taxes owed. It reflects the company's tax obligations and effective tax rate.

Income Tax Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Income Tax Expense's SCYNEXIS historically and in real time.

Access this data via the Eulerpool API

Income Statement — SCYNEXIS

All Key Metrics — SCYNEXIS